| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-13 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.25 | 1e-12 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.21 | 2e-12 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.24 | 5e-11 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-10 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.2 | 7e-10 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.18 | 3e-09 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |